ABCL
Price
$12.24
Change
+$0.53 (+4.53%)
Updated
Oct 21 closing price
Capitalization
3.97B
18 days until earnings call
Intraday BUY SELL Signals
AXON
Price
$402.60
Change
+$9.96 (+2.54%)
Updated
Oct 21 closing price
Capitalization
32.71B
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs AXON

ABCL vs AXON Comparison Chart in %
View a ticker or compare two or three
VS
ABCL vs. AXON commentary
Oct 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and AXON is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ABCL with price predictions
Oct 21, 2026

ABCL in downward trend: price may drop because broke its higher Bollinger Band on September 29, 2026

ABCL broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 40 similar instances where the stock broke above the upper band. In 37 of the 40 cases the stock fell afterwards. This puts the odds of success at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ABCL moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 25 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ABCL as a result. In 75 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

The Moving Average Convergence Divergence Histogram (MACD) for ABCL turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 33 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

ABCL moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +5.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABCL advanced for three days, in 204 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

The Aroon Indicator entered an Uptrend today. In 128 of 165 cases where ABCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.427) is normal, around the industry mean (2.988). P/E Ratio (-22.667) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (53.191) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ABCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for AXON with price predictions
Oct 21, 2026

AXON's RSI Indicator ascending out of oversold territory

The RSI Indicator for AXON moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In 26 of the 28 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 56 cases where AXON's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for AXON just turned positive on October 06, 2026. Looking at past instances where AXON's MACD turned positive, the stock continued to rise in 28 of 38 cases over the following month. The odds of a continued upward trend are 74%.

Following a +5.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 273 of 369 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for AXON entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. AXON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.901) is normal, around the industry mean (4.905). AXON has a moderately high P/E Ratio (162.996) as compared to the industry average of (16.553). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (2.564). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.330).

FUNDAMENTALS RATINGS
ABCL vs AXON: Fundamental Ratings
ABCL
AXON
OUTLOOK RATING
1..100
7064
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
10071
SMR RATING
1..100
9481
PRICE GROWTH RATING
1..100
3464
P/E GROWTH RATING
1..100
9749
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABCL's Valuation (9) in the null industry is significantly better than the same rating for AXON (92) in the Biotechnology industry. This means that ABCL’s stock grew significantly faster than AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as ABCL (100) in the null industry. This means that AXON’s stock grew similarly to ABCL’s over the last 12 months.

AXON's SMR Rating (81) in the Biotechnology industry is in the same range as ABCL (94) in the null industry. This means that AXON’s stock grew similarly to ABCL’s over the last 12 months.

ABCL's Price Growth Rating (34) in the null industry is in the same range as AXON (64) in the Biotechnology industry. This means that ABCL’s stock grew similarly to AXON’s over the last 12 months.

AXON's P/E Growth Rating (49) in the Biotechnology industry is somewhat better than the same rating for ABCL (97) in the null industry. This means that AXON’s stock grew somewhat faster than ABCL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABCLAXON
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
Bearish Trend 3 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
59%
COMPARISON
Comparison
Oct 22, 2026
Stock price -- (ABCL: $12.24 vs. AXON: $402.60)
Brand notoriety: ABCL and AXON are both not notable
ABCL represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: ABCL: 62% vs. AXON: 99%
Market capitalization -- ABCL: $3.97B vs. AXON: $32.71B
ABCL [@Biotechnology] is valued at $3.97B. AXON’s [@Aerospace & Defense] market capitalization is $32.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.95B. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $4.49 to $2.1T. The average market capitalization across the [@Biotechnology] industry is $2.18B. The average market capitalization across the [@Aerospace & Defense] industry is $40.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 1 FA rating(s) are green while AXON’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 1 green, 4 red.
  • AXON’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than AXON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while AXON’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 5 bearish.
  • AXON’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, AXON is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -1.05% price change this week, while AXON (@Aerospace & Defense) price change was -1.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.90%. For the same industry, the average monthly price growth was -15.91%, and the average quarterly price growth was -14.30%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -0.47%. For the same industry, the average monthly price growth was -15.70%, and the average quarterly price growth was -16.30%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 09, 2026.

AXON is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Biotechnology (+1.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (-0.47% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

View a ticker or compare two or three
ABCL
Daily Signal:
Gain/Loss:
AXON
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AMKL4.490.40
+9.78%
Defiance Daily Target 2X Long AMKR ETF (AMKL)
AIFD50.570.96
+1.93%
TCW Artificial Intelligence ETF (AIFD)
PABU79.680.54
+0.68%
iShares Paris-Aligned Climate Optimized MSCI USA ETF (PABU)
THEQ30.500.15
+0.50%
T. Rowe Price Hedged Equity ETF
GXC82.99-1.13
-1.35%
State Street SPDR S&P China ETF (GXC)

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+4.53%
RXRX - ABCL
57%
Loosely correlated
-0.55%
CRSP - ABCL
56%
Loosely correlated
+1.24%
ABSI - ABCL
56%
Loosely correlated
+10.69%
VCYT - ABCL
56%
Loosely correlated
+3.19%
AXON - ABCL
51%
Loosely correlated
+2.54%
More